These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 6471932)

  • 21. Treatment of seizures in a patient with Batten's disease.
    Patel NC; Davenport RD; Patel HN
    Nurse Pract; 2008 Oct; 33(10):6-9. PubMed ID: 18953233
    [No Abstract]   [Full Text] [Related]  

  • 22. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
    Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
    Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J; Zelig O; Fibach E
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Batten disease: new research findings on the biochemical defect.
    Wolfe LS; Ng Ying Kin NM
    Birth Defects Orig Artic Ser; 1982; 18(6):233-9. PubMed ID: 7171758
    [No Abstract]   [Full Text] [Related]  

  • 25. Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms.
    Dyken P; Wisniewski K
    Am J Med Genet; 1995 Jun; 57(2):150-4. PubMed ID: 7668320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunelectronmicroscopic characterization of T4 and T8 lymphocytes and natural killer cells in neuronal ceroid-lipofuscinosis.
    Kieseier BC; Goebel HH
    Am J Med Genet; 1995 Jun; 57(2):222-4. PubMed ID: 7668333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fundus dystrophy and ceroid-lipofuscinosis].
    Bischof G; Hammerstein W; Goebel HH
    Fortschr Ophthalmol; 1983; 80(2):97-9. PubMed ID: 6618378
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis.
    Worgall S; Kekatpure MV; Heier L; Ballon D; Dyke JP; Shungu D; Mao X; Kosofsky B; Kaplitt MG; Souweidane MM; Sondhi D; Hackett NR; Hollmann C; Crystal RG
    Neurology; 2007 Aug; 69(6):521-35. PubMed ID: 17679671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal ceroid lipofuscinoses and possible pathogenic mechanism.
    Zhong N
    Mol Genet Metab; 2000; 71(1-2):195-206. PubMed ID: 11001811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Terminal complement complex in blood of patients with neurological diseases.
    Ionescu DA; Jipescu I; HaĊ£egan D
    Rom J Neurol Psychiatry; 1993; 31(2):105-10. PubMed ID: 8217740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The Ia. Ia. Kal'f-Kalif leukocyte index of poisoning in certain neurological diseases].
    Zaikin VS
    Voen Med Zh; 1969 Aug; 8():76-7. PubMed ID: 5356167
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood group in neurological diseases.
    Kalyanaraman S; Kanaka TS
    Neurol India; 1967; 15(3):133-5. PubMed ID: 5600659
    [No Abstract]   [Full Text] [Related]  

  • 33. Citrate studies in some neurological disorders.
    Mascreen M; Snehalata C; Valmikinathan K
    Neurol India; 1973 Mar; 21(1):37-40. PubMed ID: 4764480
    [No Abstract]   [Full Text] [Related]  

  • 34. Antioxidant therapy in neurological disorders.
    Muller DP
    Adv Exp Med Biol; 1990; 264():475-84. PubMed ID: 2244528
    [No Abstract]   [Full Text] [Related]  

  • 35. Trace-element determination in individual peripheral blood cells and possible diagnostic applications.
    Lindh U; Johansson E
    Biol Trace Elem Res; 1987 Apr; 12(1):351-62. PubMed ID: 24254614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Appraisal of the methodology and applications for measurement of the zinc content of blood components as indicators of zinc status.
    Wallwork JC
    Biol Trace Elem Res; 1987 Apr; 12(1):335-50. PubMed ID: 24254613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI of neuronal ceroid lipofuscinosis. I. Cranial MRI of 30 patients with juvenile neuronal ceroid lipofuscinosis.
    Autti T; Raininko R; Vanhanen SL; Santavuori P
    Neuroradiology; 1996 Jul; 38(5):476-82. PubMed ID: 8837098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elemental profiles of blood cells in certain neurological disorders.
    Johansson E; Lindh U; Alanen T; Westermarck T; Heiskala H; Santavuori P; Elovaara I
    Med Biol; 1984; 62(2):139-42. PubMed ID: 6471932
    [No Abstract]   [Full Text] [Related]  

  • 39. Altered elemental profiles in neuronal ceroid lipofuscinosis.
    Johansson E; Lindh U; Westermarck T; Heiskala H; Santavuori P
    J Trace Elem Electrolytes Health Dis; 1990 Sep; 4(3):139-42. PubMed ID: 2136129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant therapy in neuronal ceroid-lipofuscinosis.
    Santavuori P; Westermarck T
    Med Biol; 1984; 62(2):152-3. PubMed ID: 6471935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.